Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis-Reference-Cited by-同舟云学术

Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis

Published:2020-05-19 Issue:10 Volume:12 Page:9405-9426
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Zhang Xue¹,Zhang Yiming¹,Li Rui¹,Zhu Lingpeng²,Fu Buqing³,Yan Tianhua¹

Affiliation:

1. Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China

2. Center of Clinical Research, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China

3. Department of Inspection, The Affiliated Jiangsu Province Hospital of Chinese Medicine of Nanjing University of Chinese Medicine, Nanjing 210009, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dazhu Hongjingtian injection attenuated alcohol-induced depressive symptoms by inhibiting hippocampus oxidative stress and inflammation through Nrf2/HO-1/NLRP3 signaling pathway;Journal of Ethnopharmacology;2024-11

2. Salidroside promotes liver regeneration after partial hepatectomy in mice by modulating NLRP3 inflammasome-mediated pyroptosis pathway;Biochemical and Biophysical Research Communications;2024-11

3. Pharmacodynamical research of extracts and compounds in traditional Chinese medicines for Parkinson's disease;Fitoterapia;2024-09

4. Deciphering the microbial map and its implications in the therapeutics of neurodegenerative disorder;Ageing Research Reviews;2024-09

5. Role of gasdermin D in inflammatory diseases: from mechanism to therapeutics;Frontiers in Immunology;2024-08-26